Guillain-Barré syndrome classification

Guillain-Barré syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Guillain-Barré syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Guillain-Barré syndrome classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Guillain-Barré syndrome classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Guillain-Barré syndrome classification
CDC on Guillain-Barré syndrome classification
Guillain-Barré syndrome classification in the news
Blogs on Guillain-Barré syndrome classification
Directions to Hospitals Treating Guillain-Barré syndrome
Risk calculators and risk factors for Guillain-Barré syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, MBBS [2]

Classification

Guillain barre syndrome may be classified according to the underlying pathophysiology into four groups:

Subtypes	explanetion
Acute Motor Axonal Neuropathy (AMAN)	The most common type (85-90%). Prior infection can trigger it. Autoimmune disorder. The target is schwann cell surface membrane or the myelin. Causes demyelination. In electrodiagnostic tests we can see slowing of nerve conduction. In pathology we can see lymphocytic infiltration of peripheral nerves and macrophage invasion of myelin sheath and schwann cells.
Acute Motor Axonal Neuropathy (AMAN)	It’s common among Chinese and Japanese people. It can be triggered by C. jejuni. It is associated with antiganglioside antibodies. Autoimmune disorder. Target is axonal membrane. Causes axonal degeneration in motor neurons. In electrodiagnostic study we can see reduction of compound muscle action potential.
Acute motor and sensory axonal neuropathy	The incidence rate is under 10%. Causes axonal degeneration. It is similar with AMAN but involves both motor and sensory axons.
Miller Fisher syndrome	Causes a clinical triad: ophthalmoplegia, ataxia and areflexia. Associated with ganglioside GQ1b antibody.